CEO Bob Proulx Featured on Biotech2050 Podcast

CEO Bob Proulx Featured on Biotech2050 Podcast

Earlier this year Imagion Biosystems CEO Bob Proulx was invited to be a guest and record an episode of the Biotech2050 podcast. The COVID-19 pandemic delayed production, but we are now pleased to share the podcast.

Biotech2050 is a US life sciences industry podcast that chronicles innovation, disruptive technologies, and trends across the sector. It is hosted by Dr Alok Tayi and Rahul Chaturvedi.

In this episode, Bob shares his career highlights to-date and explains the unique properties of MagSense technology from Imagion Biosystems that may enable it to detect cancer with higher sensitivity and specificity than today’s imaging methods.

You can listen to the recording here.

Related Articles

Successful Placement of A$3M

Imagion Biosystems (ASX: IBX) (Company), is pleased to announce the Company has received $3 million of firm commitments through a highly successful capital raising. The

Read More

Transforming medical imaging for early disease detection

We’re on a mission to make cancer more detectable.